ALBUQUERQUE, N.M., Oct. 28, 2024 /PRNewswire/ -- T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today that it ...
BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: Genomic Vision (FR0011799907 – GV – the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly ...
Peer-reviewed paper reveals proteomic assay's strong analytical capabilities, enabling robust and reproducible predictions for truly personalized treatment guidance In an era marked by technological ...
The CNSide ® CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases. The superior clinical utility of CNSide ® over ...
QUEBEC CITY, Feb. 15, 2012 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US ...
Validated Assay Can Test for Interferon Activity in Pediatric Inflammatory Diseases Using Biomarkers
The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ranges for flow cytometry quantification that are unique to each lab.
SAN DIEGO--(BUSINESS WIRE)--Assay Depot announced today that it raised $1.7 million from private investors. The funds will be used to expand the company's cloud-based pharmaceutical research platform.
IO360º today announced the 2026 sponsoring companies of the 12th annual Immuno-Oncology 360º Summit (IO360°) to date, who provide the capabilities the IO marketplace needs to advance the science.
The clock is up on Biogen’s extra two years of a biosimilar-free U.S. market for its blockbuster multiple sclerosis (MS) med ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback